Loading
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jun 2026 for Centessa Pharmaceuticals plc.
Filing timeline
BuySaleArjun Goyal
Insider track record
Disclosed buys
4
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+33.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Arjun Goyal: trading record in brief
Arjun Goyal (board member) discloses dealings in Centessa Pharmaceuticals plc to SEC (Form 4). Over a trading history stretching from 2 June 2021 to 24 June 2026, the count stands at 7 filings.
No open-market sale appears; the market trades are 4 purchases worth €17.5M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
A typical purchase (the median) is worth €2.6M. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The record was last updated on 24 June 2026 with a transaction in Centessa Pharmaceuticals plc. The last purchase on record was published on 19 May 2025, which is 522 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Arjun Goyal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
462,585 sharesOrdinary SharesSEC:0001470831-26-000613:0
44,939 shares@ US$12.2441100.0% of flowOrdinary SharesSEC:0001847903-25-000074:0
Canonical exit: 13 Aug 2025 (T+90)
3,095,909 sharesOrdinary SharesSEC:0000899243-21-022066:0
3 of 3 declarations
